Researchers develop targeted alpha therapy protocol for prostate cancer
Determines most effective therapy with the least number of side effects
Eyeing theranostics, Sofie Biosciences completes acquisition of Zevacor Pharma
Growth of FDG also influenced decision
Blue Earth Diagnostics partners with GE to manufacture Axumin PET agent in UK
Agreements were made in other European countries
RefleXion Medical selects MedCrypt to secure its new radiotherapy technology
Updated FDA guidelines put cybersecurity at forefront
PET imaging used for the first time to evaluate Zika virus in mouse model
May aid in development of therapeutic agents
Philips introduces its CardioMD IV SPECT system at ASNC meeting
Smaller footprint and lower cost of ownership
PET/MR scans can assess pediatric cancer survivor health
Study targets chemotherapy after-effects in young patients
New publication calls for greater research and investment in theranostics
Imaging a future with dedicated theranostics treatment centers
Imaging technology scans reveal trend in kidney cancer rates may be at an end
Used CT, MRI, PET and ultrasound scans
Researchers develop method that generates multi-color MR images
Requires the use of two contrast agents
Siemens Healthineers collaborates with Houston Methodist Hospital
Will provide advanced angio, MR, CT, molecular imaging and ultrasound technology